- Home
- HSTM vs AVBP Comparison
HSTM vs AVBP Comparison
Compare HSTM & AVBP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- HSTM
- AVBP
- Stock Information
- Founded
- HSTM 1990
- AVBP 2021
- Country
- HSTM United States
- AVBP United States
- Employees
- HSTM N/A
- AVBP N/A
- Industry
- HSTM Computer Software: Programming Data Processing
- AVBP
- Sector
- HSTM Technology
- AVBP
- Exchange
- HSTM Nasdaq
- AVBP NYSE
- Market Cap
- HSTM 851.7M
- AVBP 705.8M
- IPO Year
- HSTM 2000
- AVBP 2024
- Fundamental
- Price
- HSTM $26.60
- AVBP $25.22
- Analyst Decision
- HSTM Hold
- AVBP Strong Buy
- Analyst Count
- HSTM 2
- AVBP 7
- Target Price
- HSTM $29.00
- AVBP $39.29
- AVG Volume (30 Days)
- HSTM 227.2K
- AVBP 389.9K
- Earning Date
- HSTM 07-21-2025
- AVBP 08-13-2025
- Dividend Yield
- HSTM 0.47%
- AVBP N/A
- EPS Growth
- HSTM 8.37
- AVBP N/A
- EPS
- HSTM 0.63
- AVBP N/A
- Revenue
- HSTM $292,371,000.00
- AVBP N/A
- Revenue This Year
- HSTM $5.00
- AVBP $66.25
- Revenue Next Year
- HSTM $5.20
- AVBP N/A
- P/E Ratio
- HSTM $42.34
- AVBP N/A
- Revenue Growth
- HSTM 3.36
- AVBP N/A
- 52 Week Low
- HSTM $25.72
- AVBP $15.47
- 52 Week High
- HSTM $34.24
- AVBP $36.37
- Technical
- Relative Strength Index (RSI)
- HSTM 33.10
- AVBP 67.19
- Support Level
- HSTM $27.16
- AVBP $22.65
- Resistance Level
- HSTM $28.65
- AVBP $25.80
- Average True Range (ATR)
- HSTM 0.59
- AVBP 1.32
- MACD
- HSTM -0.02
- AVBP 0.18
- Stochastic Oscillator
- HSTM 26.13
- AVBP 87.89
About HSTM HealthStream Inc.
HealthStream Inc provides workforce and provider solutions for healthcare organizations. Its reportable segments include Workforce Solutions and Provider Solutions. Workforce development solutions consist of SaaS, subscription-based products that are used by healthcare organizations. Its Provider Solutions products offer healthcare organizations software applications for administering and tracking provider credentialing, privileging, call center and enrollment activities. The company generates a majority of its revenue from Subscription Services.
About AVBP ARRIVENT BIOPHARMA INC
ArriVent BioPharma Inc is a clinical-stage biopharmaceutical company dedicated to the identification, development, and commercialization of differentiated medicines to address the unmet medical needs of patients with cancers. It seeks to utilize the team's deep drug development experience to maximize the potential of the lead development candidate, furmonertinib, and advance a pipeline of novel therapeutics, such as next-generation antibody-drug conjugates, through approval and commercialization in patients suffering from cancer, with an initial focus on solid tumors.